Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Operating Expenses (2019 - 2025)

Korro Bio's Other Operating Expenses history spans 4 years, with the latest figure at $34.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $34.5 million, compared with a TTM value of $34.5 million through Dec 2025, changed N/A, and an annual FY2025 reading of $30.9 million, changed N/A over the prior year.
  • Other Operating Expenses for Q4 2025 was $34.5 million at Korro Bio, down from $54.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $54.8 million in Q4 2023, with the low at $34.5 million in Q4 2025.